Trial Profile
A Phase II trial of PMZ-1620 for the treatment of neurovascular diseases
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 21 Sep 2016
Price :
$35
*
At a glance
- Drugs Sovateltide (Primary)
- Indications Cerebrovascular disorders; Neurodegenerative disorders; Vascular disorders
- Focus Therapeutic Use
- 21 Sep 2016 New trial record